HomeCompareBDX vs ICE

BDX vs ICE: Dividend Comparison 2026

BDX yields 2.27% · ICE yields 1.25%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ICE wins by $82.1K in total portfolio value· pulled ahead in Year 3
10 years
BDX
BDX
● Live price
2.27%
Share price
$154.69
Annual div
$3.51
5Y div CAGR
13.5%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$26.9K
Annual income
$1,058.14
Full BDX calculator →
ICE
ICE
● Live price
1.25%
Share price
$156.94
Annual div
$1.96
5Y div CAGR
59.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$109.0K
Annual income
$44,156.55
Full ICE calculator →

Portfolio growth — BDX vs ICE

📍 ICE pulled ahead of the other in Year 3

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBDXICE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BDX + ICE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BDX pays
ICE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BDX
Annual income on $10K today (after 15% tax)
$192.91/yr
After 10yr DRIP, annual income (after tax)
$899.42/yr
ICE
Annual income on $10K today (after 15% tax)
$106.16/yr
After 10yr DRIP, annual income (after tax)
$37,533.07/yr
At 15% tax rate, ICE beats the other by $36,633.65/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BDX + ICE for your $10,000?

BDX: 50%ICE: 50%
100% ICE50/50100% BDX
Portfolio after 10yr
$68.0K
Annual income
$22,607.34/yr
Blended yield
33.26%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ICE right now

BDX
Analyst Ratings
16
Buy
16
Hold
1
Sell
Consensus: Buy
Price Target
$193.80
+25.3% upside vs current
Range: $170.00 — $215.00
Altman Z
2.1
Piotroski
8/9
ICE
Analyst Ratings
1
Strong
32
Buy
3
Hold
Consensus: Buy
Price Target
$192.86
+22.9% upside vs current
Range: $180.00 — $211.00
Altman Z
0.9
Piotroski
8/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BDX buys
0
ICE buys
0
No recent congressional trades found for BDX or ICE in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBDXICE
Forward yield2.27%1.25%
Annual dividend / share$3.51$1.96
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR13.5%59.6%
Portfolio after 10y$26.9K$109.0K
Annual income after 10y$1,058.14$44,156.55
Total dividends collected$5.7K$83.1K
Payment frequencyquarterlyquarterly
SectorHealthcareFinancials
Analyst consensusBuyBuy
Analyst price target$193.80$192.86

Year-by-year: BDX vs ICE ($10,000, DRIP)

YearBDX PortfolioBDX Income/yrICE PortfolioICE Income/yrGap
1$10,958$257.59$10,899$199.32+$59.00BDX
2$12,024$299.40$11,986$324.04+$38.00BDX
3← crossover$13,214$348.50$13,357$531.54$143.00ICE
4$14,545$406.26$15,175$883.50$630.00ICE
5$16,038$474.35$17,735$1,497.24$1.7KICE
6$17,715$554.80$21,586$2,609.94$3.9KICE
7$19,606$650.06$27,836$4,738.36$8.2KICE
8$21,741$763.12$38,898$9,113.83$17.2KICE
9$24,161$897.64$60,617$18,996.59$36.5KICE
10$26,910$1,058.14$109,017$44,156.55$82.1KICE

BDX vs ICE: Complete Analysis 2026

BDXHealthcare

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes; and prefillable drug delivery systems. Its BD Life Sciences segment provides specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment offers hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is based in Franklin Lakes, New Jersey.

Full BDX Calculator →

ICEFinancials

Intercontinental Exchange, Inc., together with its subsidiaries, operates regulated exchanges, clearing houses, and listings venues for commodity, financial, fixed income, and equity markets in the United States, the United Kingdom, the European Union, Singapore, Israel, and Canada. It operates through three segments: Exchanges, Fixed Income and Data Services, and Mortgage Technology. The company operates marketplaces for listing, trading, and clearing an array of derivatives contracts and financial securities, such as commodities, interest rates, foreign exchange, and equities, as well as corporate and exchange-traded funds; trading venues, including 13 regulated exchanges and 6 clearing houses; and offers futures and options products for energy, agricultural and metals, financial, cash equities and equity, over-the-counter, and other markets, as well as listings and data and connectivity services. It also provides fixed income data and analytic, fixed income execution, CDS clearing, and other multi-asset class data and network services. In addition, the company offers proprietary and comprehensive mortgage origination platform, which serves residential mortgage loans; closing solutions that provides customers connectivity to the mortgage supply chain and facilitates the secure exchange of information; data and analytics services; and Data as a Service for lenders to access data and origination information. Intercontinental Exchange, Inc. was founded in 2000 and is headquartered in Atlanta, Georgia.

Full ICE Calculator →
📬

Get this BDX vs ICE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BDX vs SCHDBDX vs JEPIBDX vs OBDX vs KOBDX vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.